Related Experiment Video
Updated: Mar 9, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
Cardiovascular Effects of Performance-Enhancing Drugs
André La Gerche1, Maria J Brosnan2
1From Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (A.L.G., M.J.B.); St Vincent's Hospital, Fitzroy, Victoria, Australia (A.L.G., M.J.B.); and Department of Cardiovascular Medicine, University of Leuven, Belgium (A.L.G.). andre.agerche@bakeridi.edu.au.
Performance-enhancing drugs (PEDs) pose health risks beyond direct cardiovascular effects, including exercise-induced arrhythmias. Athletes may face dangers from novel, unmonitored agents before regulatory awareness.
Area of Science:
- Sports Medicine
- Pharmacology
- Cardiology
Background:
- Competitive sports offer health benefits but face threats from performance-enhancing agents.
- Performance-enhancing drugs (PEDs) carry significant health risks and create unfair advantages.
- Beyond direct cardiovascular effects, PEDs may indirectly cause exercise-induced arrhythmias by enabling athletes to exceed physiological limits.
Purpose of the Study:
- To review the known health effects of PEDs.
- To highlight the emerging threat of novel, unrecognized performance-enhancing agents.
- To discuss the potential for exercise-induced arrhythmias linked to PED use.
Main Methods:
- Literature review of existing research on PEDs and their health effects.
- Analysis of the indirect consequences of PEDs on athletic performance and cardiac health.
- Discussion of the time lag between athlete use of novel agents and regulatory detection.
Main Results:
- PEDs can directly impact the cardiovascular system (myocardium, vasculature, metabolism).
- Indirect effects of PEDs may lead to exercise-induced arrhythmias by pushing athletes beyond safe physiological boundaries.
- Athletes often experiment with novel agents lacking efficacy and safety data, posing unmonitored risks.
Conclusions:
- The covert use of unrecognized performance-enhancing agents represents a significant health threat in sports.
- The delay in regulatory awareness of new agents creates a window for athletes to use them with relative impunity.
- Addressing PED abuse may require considering all off-label drug use as illegal.
Related Concept Videos
Pathophysiology of Cardiac Performance
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be...
Heart Failure Drugs: β-Blockers

